ClinicalTrials.Veeva

Menu

Systemic Immune Inflammatory Index in Systemic Lupus Erythematosus

S

Sohag University

Status

Enrolling

Conditions

Lupus Nephritis
Systemic Lupus Erythematosus

Treatments

Diagnostic Test: systemic immune inflammatory index

Study type

Observational

Funder types

Other

Identifiers

NCT06796569
soh-Med-25-1-2MD

Details and patient eligibility

About

This study aims to investigate the association between the systemic immune-inflammation index and disease activity, as well as lupus nephritis in patients with systemic lupus erythematosus

Enrollment

90 estimated patients

Sex

All

Ages

16+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • o Older than 16 years

    • In a patient with SLE, patients who fulfill the criteria of the American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR).
    • In patients with LN, patients whose diagnosis is confirmed by kidney biopsy and pathohistological verification (WHO classification, and the International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification.

Exclusion criteria

  • Patients with other autoimmune rheumatological diseases, lymphoproliferative disorders, malignancies, liver diseases, end-stage kidney disease, diabetic nephropathy, active infections, recent history of blood transfusion and patients with deficiencies in vitamin B12, folate, and iron are excluded from the study.

Trial design

90 participants in 3 patient groups

patients diagnosed with systemic lupus and lupus nephritis
Description:
this group will include 30 patients, all patients will undergo the following: For the evaluation of SLE clinical disease activity SLEDAI ( systemic upus erythematosus disease activity index)scores will be recorded The SII (systemic immune inflammatory index) will be calculatedusing the following formula: SII = (neutrophil count × platelet count)/lymphocyte count.
Treatment:
Diagnostic Test: systemic immune inflammatory index
patients diagnosed with systemic lupus without lupus nephritis
Description:
this group will also include 30 patients, all patients will undergo the following: For the evaluation of SLE clinical disease activity SLEDAI ( systemic upus erythematosus disease activity index)scores will be recorded The SII (systemic immune inflammatory index) will be calculated using the following formula: SII = (neutrophil count × platelet count)/lymphocyte count.
Treatment:
Diagnostic Test: systemic immune inflammatory index
healthy control group
Description:
this group will also include 30 healthy controls , they will undergo the following: The SII (systemic immune inflammatory index) will be calculated using the following formula: SII = (neutrophil count × platelet count)/lymphocyte count.
Treatment:
Diagnostic Test: systemic immune inflammatory index

Trial contacts and locations

1

Loading...

Central trial contact

Shorouk Mohamed abdelmageed, master degree

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems